154
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery

, , , , , & show all
Pages 5489-5503 | Published online: 28 Aug 2015

References

  • MitragotriSBurkePALangerROvercoming the challenges in administering biopharmaceuticals: formulation and delivery strategiesNat Rev Drug Discov20141365567225103255
  • McLornanDPListAMuftiGJApplying synthetic lethality for the selective targeting of cancerN Engl J Med20143711725173525354106
  • RousseauAMarquetPApplication of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugsFundam Clin Pharmacol20021625326212570013
  • PaciAVealGBardinCReview of therapeutic drug monitoring of anticancer drugs. Part 1. CytotoxicsEur J Cancer2014502010201924889915
  • WidmerNBardinCChatelutEReview of therapeutic drug monitoring of anticancer drugs. Part two – targeted therapiesEur J Cancer2014502020203624928190
  • MarchettiCPalaiaIGiorginiMTargeted drug delivery via folate receptors in recurrent ovarian cancer: a reviewOnco Targets Ther201471223123625031539
  • McCruddenCMMcCarthyHOCurrent status of gene therapy for breast cancer: progress and challengesAppl Clin Genet2014720922025419154
  • RyanSMBraydenDJProgress in the delivery of nanoparticle constructs: towards clinical translationCurr Opin Pharmacol201418C12012825450066
  • KajimotoKSatoYNakamuraTYamadaYHarashimaHMultifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivoJ Control Release201419059360624794902
  • NicholsJWBaeYHEPR: evidence and fallacyJ Control Release201419045146424794900
  • ChoHYLeeYBNano-sized drug delivery systems for lymphatic deliveryJ Nanosci Nanotechnol20141486888024730304
  • OrzaACascianoDBirisANanomaterials for targeted drug delivery to cancer stem cellsDrug Metab Rev20144619120624697156
  • HubbellJAChikotiANanomaterials for drug deliveryScience201233730330522822138
  • Kapse-MistrySGovenderTSrivastavaRYergeriMNanodrug delivery in reversing multidrug resistance in cancer cellsFront Pharmacol2014515925071577
  • BegSRizwanMSheikhAMHasnainMSAnwerKKohliKAdvancement in carbon nanotubes: basics, biomedical applications and toxicityJ Pharm Pharmacol20116314116321235578
  • CabralHKataokaKProgress of drug-loaded polymeric micelles into clinical studiesJ Control Release201419046547624993430
  • ZhaoYLinDWuFDiscovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug deliveryInt J Mol Sci201415175651757625268623
  • JeongYIKimYWJungSDelivery of transferrin-conjugated polysaccharide nanoparticles in 9L gliosarcoma cellsJ Nanosci Nanotechnol201515125129
  • AbbasiEAvalSFAkbarzadehADendrimers: synthesis, applications, and propertiesNanoscale Res Lett2014924724994950
  • JainKJainNKSurface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancerJ Nanosci Nanotechnol2014145075508724757983
  • LyulinSVVattulainenIGurtovenkoAAComplexes comprised of charged dendrimers, linear polyelectrolytes, and counterions: insight through coarse-grained molecular dynamics simulationsMacromolecules20084149614968
  • EleftheriouEKaratasosKModeling the formation of ordered nano-assemblies comprised by dendrimers and linear polyelectrolytes: the role of Coulombic interactionsJ Chem Phys201213714490523061863
  • YangRXiaSYeTSynthesis of a novel polyamidoamine dendrimer conjugating with alkali blue as a lymphatic tracer and study on the lymphatic targeting in vivoDrug Deliv11192014 Epub ahead of print
  • HeXAlvesCSOliveiraNRGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cellsColloids Surf B Biointerfaces2015125828925437067
  • KaminskasLMKellyBDMcLeodVMCapping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimersMol Pharm2011833834921171585
  • BervarAZajcISeverNKatunumaNSloaneBFLahTTInvasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitorsBiol Chem200338444745512715895
  • DuncanRSat-KlopschYNBurgerAMBibbyMCFiebigHHSausvilleEAValidation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rateCancer Chemother Pharmacol20137241742723797686
  • ChenZZhangPCheethamAGControlled release of free doxorubicin from peptide-drug conjugates by drug loadingJ Control Release201419112313024892976
  • ManigandaSSankarVNairJBRaghuKGMaitiKKA lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapyOrg Biomol Chem2014126564656925062087
  • AlencarHFunovicsMAFigueiredoJSawayaHWeisslederRMahmoodUColonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection – study in miceRadiology200724423223817507718
  • AdenisAHuetGZerimechFHecquetBBalduyckMPeyratJPCathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parametersCancer Lett1995962672757585467
  • KuesterDLippertHRoessnerAKruegerSThe cathepsin family and their role in colorectal cancerPathol Res Pract200820449150018573619
  • FunovicsMAAlencarHMontetXWeisslederRMahmoodUSimultaneous fluorescence imaging of protease expression and vascularity during murine colonoscopy for colonic lesion characterizationGastrointest Endosc20066458959716996355